Jeremy Force, DO

Articles

Question and Answer Session

January 19th 2022

Dr Gary Ulaner and Dr Jeremy Force answer questions submitted by attendees of the live webinar discussing the role of various strategies to detect estrogen receptor (ER)-positive breast cancer, with particular focus on the role of 18-F FES-PET imaging in diagnosis and treatment of ER-positive breast cancer.

FES-PET in the Treatment of Patients With Breast Cancer: Clinical Case 3

January 19th 2022

Dr Jeremy Force illustrates how FES-PET aids in the treatment of patients with breast cancer through a clinical case.

FES-PET in the Treatment of Patients with Breast Cancer: Clinical Case 2

January 19th 2022

Dr Jeremy Force illustrates how FES-PET aids in the treatment of patients with breast cancer through a clinical case.

FES-PET in the Care of Patients With Breast Cancer: Clinical Case 1

January 12th 2022

Dr Jeremy Force illustrates how FES-PET aids in the care of patients with breast cancer through a clinical case.

Is There a Role for FES-PET Imaging in Assessing ER Status and Extent?

January 12th 2022

A comprehensive analysis of the potential role of FES-PET imaging in assessing ER status in tumors that are difficult to biopsy and in evaluating the extent of disease.

Applications of FES-PET Imaging in Breast Cancer Treatment Decision-Making

January 5th 2022

Expert perspective on the applications of FES-PET imaging in treatment decision-making in patients with breast cancer.

Role of FDG-PET Vs FES-PET in ER+ Breast Cancer

January 5th 2022

Dr Gary Ulaner compares the role of FDG-PET and FES-PET imaging in ER+ Breast Cancer and the ability of each of the 2 techniques in assessing ER status.

Overview of Estrogen Receptor-Targeted Imaging

December 22nd 2021

Experts provide an overview of the imaging modalities that can detect estrogen receptor status in patients with breast cancer.

ER-Positive Breast Cancer and ER Testing Strategies

December 22nd 2021

Gary Ulaner, MD, PhD and Jeremy Force, DO review estrogen receptor (ER)-positive breast cancer and the various strategies available for diagnosing estrogen receptor (ER)-positive breast cancer.